-
KEYTRUDA® (pembrolizumab) and KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph), Plus Paclitaxel ± Bevacizumab, Approved for Certain Adults with PD-L1+ (CPS ≥1) Platinum-Resistant Ovarian Carcinoma as Second or Third Line Treatment
11 Feb 2026 17:30 GMT
… in metastatic non–small cell lung cancer (NSCLC), serious adverse … and CAPOX (capecitabine plus oxaliplatin) or FP (5-FU … resection.
Non-Small Cell Lung Cancer
KEYTRUDA and KEYTRUDA QLEX … metastatic nonsquamous non–small cell lung cancer (NSCLC), with no …
-
Prospects and Challenges of Chitosan-Based Drug Carriers for Anticancer Agents’ Delivery Against Lung Cancer: A Review
24 Oct 2025 14:10 GMT
… lung cancer into non-small cell lung cancer (NSCLC) and small cell lung cancer … of lung cancer.
Current treatment modalities for lung cancer include surgery … -CPT-NPs inhibited lung tumor growth by promoting … of ASPN siRNA and oxaliplatin by nanoparticles to …
-
Predictive Value of Tumor ERCC1 Expression for Treatment Outcomes After Adjuvant Chemotherapy in Patients with Completely Resected Non-Small Cell Lung Cancer
19 Jul 2025 11:24 GMT
… : non-small cell lung cancer, postoperative adjuvant chemotherapy, … resected non-small cell lung cancer. Lung Cancer. 2008;62(1 … -based concurrent chemoradiotherapy. Lung Cancer. 2010;68(2 … colorectal cancer patients receiving oxaliplatin and fluorouracil (5- …
-
The Landscape of Ferritin Nanocages for Neurodegenerative Diseases Treatment
05 Feb 2026 13:53 GMT
… S, et al. Advances in Lung Cancer Treatment Using Nanomedicines. ACS Omega … Z, et al. Glioma-targeted oxaliplatin/ferritin clathrate reversing the …
-
Investigational MK-1084 Demonstrates Antitumor Activity in Phase I Trial for Colorectal and Non-Small Cell Lung Cancers
31 May 2025 01:07 GMT
… CRC) and non-small cell lung cancer (NSCLC). Across both patient … with or without chemotherapy (oxaliplatin and leucovorin plus 5- … with non-small cell lung cancer. Based on early evidence … metastatic non-small cell lung cancer.”
Upcoming KANDLELIT-012 trial …
-
Merck Announces MK-1084, an Investigational KRAS G12C Inhibitor, Shows Antitumor Activity in Phase 1 Trial of Patients With Advanced Colorectal Cancer and Non-Small Cell Lung Cancer Whose Tumors Harbor KRAS G12C Mutations
30 May 2025 12:21 GMT
… CRC) and non-small cell lung cancer (NSCLC). In patients with … with or without chemotherapy (oxaliplatin and leucovorin plus 5- … test.
Non-Small Cell Lung Cancer
KEYTRUDA, in combination with … metastatic nonsquamous non-small cell lung cancer (NSCLC), with no …
-
Developments & Potential of Nanotechnology for the Detection and Treatment of Pancreatic Cancer
04 Feb 2026 23:47 GMT
… such as non-small cell lung cancer (NSCLC), non-Hodgkin’s … metastatic non–small-cell lung cancer with PD-L1 tumor … metastatic non-small-cell lung cancer: a systematic review of … + 5-fluorouracil/leucovorin + oxaliplatin (NALIRIFOX) versus nab-paclitaxel + …
-
Bristol Myers Squibb Receives Positive CHMP Opinion for Perioperative Regimen of Neoadjuvant Opdivo® (nivolumab) and Chemotherapy Followed by Surgery and Adjuvant Opdivo for Resectable Non-Small Cell Lung Cancer in Patients with Tumor Cell PD-L1...
28 Mar 2025 13:11 GMT
… of four tumor types: lung cancer, bladder cancer, esophageal … pathologic response.
About Lung Cancer
Lung cancer is the leading … with a fluoropyrimidine, oxaliplatin, and irinotecan. This … lung cancer; Checkmate 816–neoadjuvant non-small cell lung cancer, …
-
EMA Clears Immunotherapy for Early Gastric and GEJ Cancers
03 Feb 2026 14:34 GMT
… with FLOT chemotherapy (fluorouracil, leucovorin, oxaliplatin, and docetaxel) as neoadjuvant and … of non-small cell lung cancer, small cell lung cancer, biliary tract cancer, hepatocellular …
-
Bristol Myers Squibb Announces Opdivo® Plus Chemotherapy as the First and Only Neoadjuvant-Only Immuno-Oncology Therapy to Demonstrate Statistically Significant and Clinically Meaningful Overall Survival in Resectable Non-Small Cell Lung Cancer
19 Feb 2025 12:09 GMT
… positive) non-small cell lung cancer (NSCLC).
OPDIVO® (nivolumab … with a fluoropyrimidine, oxaliplatin, and irinotecan. This … metastatic non-small cell lung cancer, in combination with … cell lung cancer; Checkmate 816–neoadjuvant non-small cell lung cancer, …
About
© 1995-2026